ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit (ACT-ICU)
Brain Injuries, Dementia, Myopathies
About this trial
This is an interventional treatment trial for Brain Injuries focused on measuring Asthenia, Muscle Weakness, Brain Injuries, Critical Illness, Critical Illness Myoneuropathy, Rehabilitation, Sepsis, Respiratory Failure, Delirium, Over-sedation, Immobility, Aging, Signs and Symptoms, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Manifestations, Neurologic Manifestations, Pathologic Processes, Brain Diseases, Central Nervous System Diseases, Craniocerebral Trauma, Trauma, Nervous System, Wounds and Injuries, Disorders of Environmental Origin
Eligibility Criteria
Inclusion Criteria:
- Adult patients admitted to the medical or surgical ICU who are receiving treatment for respiratory failure, cardiogenic shock, hemorrhagic shock, and/or septic shock.
Exclusion Criteria:
- Moderate to severe dementia on ICU admission based on a standardized surrogate assessment (as this would prohibit patients from functioning independently at home);
- Moderate or severe physical dysfunction that precludes performance of independent activities of daily living based on a standardized surrogate assessment;
- Live greater than 120 miles from Nashville;
- Blind, deaf, or unable to speak English;
- Prisoners;
- Homelessness and no secondary contact person available
Sites / Locations
- Vanderbilt University Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Patients (Controls)
Behavioral: Phys & Func Rehab
Behavioral: Cog/Phys/Func Rehab
Patients (Controls) will not receive formal (study-related) rehabilitation interventions and will only receive usual care.
A multi-component program of physical rehabilitation interventions (without cognitive rehabilitation) will be delivered to patients beginning in the ICU and continue throughout the hospitalization.
A multi-component program of cognitive, physical, and functional rehabilitation interventions will be delivered to patients beginning in the ICU with continued cognitive rehabilitation in their home environments over a focused 12-week period.